Laboratorio Chile

What Laboratorio Chile does

Laboratorio Chile, commercially operated as "Laboratorio Chile | Teva," is a Chilean pharmaceutical company founded in 1896 and headquartered in Renca, Santiago. It functions as the Chilean subsidiary of Teva Pharmaceuticals (NYSE: TEVA), one of the world's largest generic pharmaceutical producers. The company manufactures and distributes generic and bioequivalent medications across cardiovascular, central nervous system, immunology, and oncology therapeutic areas, alongside a consumer health portfolio anchored by Clearblue digital ovulation and pregnancy tests. All products are registered with Chile's Instituto de Salud Pública, and bioequivalent products are required to demonstrate therapeutic equivalence through bioavailability studies.

The company's commercial model is a sales-led, retail-channel operation. Pharmaceutical and consumer health products reach end users through Chile's major pharmacy chains — Salcobrand, Farmacias Ahumada, Cruz Verde, Meddica, Farmazon, Cofar, TodoFarma, and Fracción — with products available across all 16 Chilean regions via a region-and-commune product availability tool on the company website. Customer segments are horizontal, split between general patients/consumers (served via the ChileSalud discount program and Musa Chile patient support program) and healthcare professionals (served via the NodoMed professional portal offering training, pharmacovigilance, and pharmaceutical resources). Pricing is not publicly disclosed; the primary pricing-related program is the ChileSalud patient discount platform, accessible at farmacias.michilesalud.cl.

Beyond commercial distribution, the company invests in disease-awareness and public health positioning through the Tómatelo en Serio campaign, the MediAudios podcast, and the "Juntos contra la falsificación" anti-counterfeiting initiative — a multi-agency partnership coordinated with Chilean customs, Carabineros, PDI, Armada de Chile, regional municipalities, and local commerce chambers. Revenue is not disclosed at the entity level; Chile is one of four core LATAM markets (alongside Brazil, Mexico, and Argentina) representing approximately 20% of Teva's International Markets segment. Parent-level signals — including a planned five-year pipeline across cardiovascular, CNS, immunology, and oncology, and a Mexico manufacturing hub producing 42 active pharmaceutical ingredients — indicate structural support for product extension at the Chilean subsidiary level.

Name

Laboratorio Chile

Legal name

Laboratorio Chile

Website

https://laboratoriochile.cl

Company type

Private

Founded year

1896

Operating status

Operating

Headcount range

501–1,000 employees

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

Keywords

• Generic pharmaceuticals
• Bioequivalent medications
• Consumer health products
• Pharmacy distribution
• Pharmaceutical manufacturing

Headquarters

HQ city

Santiago

HQ country

Chile

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales

Revenue model

1. Pharmaceutical Products: Revenue generated from the sale of generic and bioequivalent pharmaceutical medications. The company offers products in categories including cardiovascular, central nervous system, immunology, and oncology therapeutic areas. Products are sold through pharmacy retail chains across Chile.
2. Consumer Health Products: Clearblue digital ovulation and pregnancy tests sold through pharmacy retail channels including Salcobrand, Farmacias Ahumada, Cruz Verde, and other pharmacies across Chile.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Laboratorio Chile manufactures and distributes generic and bioequivalent pharmaceutical medications in therapeutic areas including cardiovascular, central nervous system, immunology, and oncology, alongside consumer health products such as Clearblue digital ovulation and pregnancy tests. The company operates as the Chilean subsidiary of Teva Pharmaceuticals, with products distributed through major pharmacy chains across Chile and supported by patient discount programs (ChileSalud, Musa) and healthcare professional resources (NodoMed).

Product overview

Laboratorio Chile | Teva is a pharmaceutical company operating as the Chilean subsidiary of Teva Pharmaceuticals, operating in key LATAM markets including Brazil, Mexico, Argentina, and Chile. The company offers a portfolio of generic and bioequivalent medications, along with consumer health products like Clearblue ovulation and pregnancy tests. Their therapeutic areas include cardiovascular, central nervous system, immunology, and oncology. The company provides patient support programs (Chile Salud, Musa), professional healthcare platforms (NodoMed), and health education content covering conditions such as VIH, cancer, migraine, COPD, and multiple sclerosis.

Differentiator

Problem solved

Functional benefit

Products and services

• Medicamentos Genéricos (Generic Medications)
• Medicamentos Bioequivalentes (Bioequivalent Medications) Bioequivalent medications that have demonstrated therapeutic equivalence to innovative reference products through bioavailability studies, meeting higher interchangeability standards than standard generics. Targeted at patients and healthcare providers seeking assured therapeutic equivalence in cardiovascular, CNS, immunology, and oncology therapeutic areas.
• Clearblue Prueba de Ovulación Digital (Clearblue Digital Ovulation Test) Digital ovulation test that identifies the 2 most fertile days of each cycle by detecting the luteinizing hormone (LH) surge in urine. Provides over 99% accuracy with clear digital display including a happy face indicator. Designed for women planning pregnancy.
• Clearblue Prueba de Embarazo Digital (Clearblue Digital Pregnancy Test) Digital pregnancy test that indicates pregnant or not pregnant with words on screen and can indicate weeks since conception (1-2, 2-3, or 3+ weeks) with 93% accuracy. Designed for women seeking clear pregnancy confirmation.
• Kitadol Pain relief medication containing paracetamol, indicated especially for tension-type headaches. Available as an over-the-counter analgesic for consumers seeking accessible pain management.

Quantifiable outcome

• Teva's LATAM operations (Brazil, Mexico, Argentina, Chile) represent approximately 20% of Teva's International Markets segment, demonstrating significant regional market presence.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration9 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Ilustre Municipalidad de San AntoniocoreStrategic or Co-development Partner · 29 September 2025Laboratorio Chile | Teva partnered with the Municipality of San Antonio in the 'Juntos contra la falsificación' campaign to provide training on intellectual property protection and medication safety. The initiative included coordination with local authorities to strengthen inter-institutional collaboration against medication counterfeiting.
• Dirección Regional de AduanascoreStrategic or Co-development Partner · 29 September 2025Collaboration with customs authorities as part of the national 'Juntos contra la falsificación' campaign to prevent counterfeit medications from entering the market and protect patient safety.
• Carabineros de ChilecoreStrategic or Co-development Partner · 29 September 2025Partnership with Chilean police force for enforcement coordination in combating medication counterfeiting under the 'Juntos contra la falsificación' campaign.
• Policía de Investigaciones (PDI)coreStrategic or Co-development Partner · 29 September 2025Collaboration with Chile's criminal investigation police for anti-counterfeiting operations and patient safety protection.
• Armada de ChilecoreStrategic or Co-development Partner · 29 September 2025Partnership with Chilean Navy for maritime border coordination against counterfeit medication trafficking.
• Cámara de Comercio local (San Antonio)minorChannel Partner/ Reseller/ Distributor · 29 September 2025Local commerce chamber partnership to educate merchants and businesses on identifying counterfeit products and supporting legitimate pharmaceutical distribution.
• Municipalidades de Santo Domingo, Cartagena, El Tabo, El Quisco y AlgarrobominorStrategic or Co-development Partner · 29 September 2025Regional municipalities participating in the 'Juntos contra la falsificación' campaign for coordinated anti-counterfeiting efforts across the Valparaíso Region.
• Teva PharmaceuticalscoreOEM/ Whitelabel/ Licensing PartnerLaboratorio Chile operates as the Chilean subsidiary and brand of Teva Pharmaceuticals, one of the world's largest generic pharmaceutical companies. Teva operates across LATAM markets including Brazil, Mexico, Argentina, and Chile, representing about 20% of Teva's International Markets segment.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Sandoz: Global generics leader (Novartis spin-off) operating across more than 100 countries. Directly comparable to Laboratorio Chile as a direct competitor in generic and bioequivalent pharmaceuticals across the same therapeutic areas (cardiovascular, CNS, oncology). Has active presence in Chile and across LATAM.
• Viatris: Global pharmaceutical company formed from Mylan and Upjohn, with a large generics portfolio across LATAM. Comparable to Laboratorio Chile in offering off-patent and generic medications in cardiovascular, CNS, and other therapeutic areas, with established Chilean and LATAM distribution.
• Apotex: One of the largest generic pharmaceutical manufacturers globally, headquartered in Canada. Comparable to Laboratorio Chile in producing generic and bioequivalent medications with global distribution networks reaching into LATAM markets.
• Abbott Laboratories: Global healthcare company with significant pharmaceutical and consumer health presence in LATAM including Chile. Comparable as a broad incumbent offering branded pharmaceuticals, consumer health products, and diagnostic devices across the same pharmacy channels.
• Bayer (Consumer Health): Global pharmaceutical and consumer health company with established operations in Chile and across LATAM. Comparable to Laboratorio Chile as a broad incumbent offering branded pharma and consumer health products in the same Chilean pharmacy retail channel.

Regional players

• Eurofarma Laboratórios: Brazilian multinational pharmaceutical company with strong presence across LATAM including Chile. Comparable as a regional generic and branded pharma peer operating similar therapeutic categories in the same Latin American geography.
• Laboratorios Bagó: Argentinian multinational pharmaceutical group with operations across Latin America. Comparable to Laboratorio Chile as a regional generic and branded pharma player with overlapping LATAM distribution and similar therapeutic focus.

Direct peers

• Laboratorios Andromaco: Chilean pharmaceutical company producing generic and branded medications for the domestic market. Direct domestic competitor to Laboratorio Chile, operating in overlapping therapeutic categories and distributed through the same pharmacy retail chains across Chile.
• Laboratorios Saval: Chilean pharmaceutical company with a broad generics and branded portfolio across multiple therapeutic areas. Direct competitor to Laboratorio Chile in the Chilean retail pharmacy channel with overlapping product categories.
• Laboratorios Mintlab: Chilean pharmaceutical company producing and distributing pharmaceutical and consumer health products domestically. Direct competitor to Laboratorio Chile in the Chilean market with overlapping distribution through major pharmacy chains.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/laboratoriochileteva
• LinkedInlinkedin.com/company/laboratoriochileteva
• Instagraminstagram.com/laboratoriochile_teva/?hl=es-la

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratorio Chile